Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
On this page, readers will find valuable insights into stocks, including investment strategies and tax implications. Understanding these topics is essential for making informed financial decisions.
510 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
GitLab delivered solid revenue growth but offered modest profitability guidance, triggering a sharp stock move. This ...
Veeva Systems prepares to unveil Q4 FY2026 after the bell, with investors weighing durable renewals against software ...
Nebius Group stock charged higher on Wednesday amid fresh AI cloud developments. This article breaks down the catalys...
February delivered a sharp 21.4% drop for BigBear.AI, widening concerns about AI stocks. This guide breaks down the d...
A notable $25.7 million position in DNOW signals institutional confidence despite an 18% drop last year. This article...
A few well-timed picks can dramatically change a portfolio. This guide breaks down what to look for and presents thre...
NVIDIA delivered a robust quarterly report, yet its shares failed to spark a lasting breakout. Investors want clearer...
February brought a sharp drop for Atlassian as investors digested earnings signals and AI risk. This guide breaks dow...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
EOSE stock has surged in a volatile stretch as investors weigh grid-scale storage growth against project risks. This ...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...